Terns Pharmaceuticals, Inc. (TERN)
40.59
-0.91
(-2.19%)
USD |
NASDAQ |
Dec 30, 16:00
40.50
-0.09
(-0.22%)
Pre-Market: 09:00
Terns Pharmaceuticals Market Cap: 3.656B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Altimmune, Inc. | 376.68M |
| Ligand Pharmaceuticals, Inc. | 3.743B |
| ADMA Biologics, Inc. | 4.370B |
| Viking Therapeutics, Inc. | 3.992B |
| Cidara Therapeutics, Inc. | 6.943B |
Market Cap Related Metrics
| Price to Book Value | 12.87 |
| Price | 40.59 |
| Earnings Yield | -2.54% |